is compounded tirzepatide being discontinued Compounded GLP-1 - Semaglutide &

Henry Meds received an FDA warning letter in March 2026 for marketing therapeutic equivalence to brand drugs

is supported by the Wellcome Trust Leicestershire Healthcare Inequalities Improvement Doctoral Training Programme (223512/Z/21/Z)

Compounded tirzepatide is not FDA-approved and has not been reviewed for quality, safety, or efficacy

Biotin supplementation is not routinely recommended for hair loss unless a confirmed deficiency has been identified, and it should be used with caution because it can interfere with common laboratory immunoassays, including thyroid function tests, potentially producing misleading results

This can result in semaglutide rebound weight gain or the tirzepatide rebound effect , where hunger returns, and old eating habits may resurface

When you stop taking Mounjaro, the medication gradually leaves your system over about a month